Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

Viral Hepatitis

Quick Links

Veterans Crisis Line Badge
My healthevet badge

Hepatitis C Quicknotes: Genotype 1

for Health Care Providers

Antiviral Treatment Strategy

Genotype 1

  1. Peginterferon alfa 2a (Pegasys) 180 mcg SC once weekly (regardless of weight) OR
  2. Peginterferon alfa 2b (PEG-Intron) 1.5 mcg/kg SC once weekly up to 150 mcg/week (see chart below) AND
  3. PEG-IFN alfa 2b Dosing
    WT (lbs)Vial Size (µg/0.5mL)PEG dose (mL)
    <88500.5
    88-110800.4
    111-141800.5
    142-1661200.4
    167-1871200.5
    >1871500.5
  4. Ribavirin (Rebetol, Copegus)
  5. RIBAVIRIN DOSE
    WT (lbs)Total Daily DosageDosing Schedule
    ≤1651,000 mg QD2 (200 mg) tablets PO morning
    3 (200 mg) tablets PO evening
    >1651,200 mg QD3 (200 mg) tablets PO BID
  6. Duration of therapy
    • If 4-week HCV RNA undetectable (RVR), 24 weeks may be sufficient
    • If no RVR, but 12-week HCV RNA undetectable or decreased by >2 log 10 (EVR), 48 weeks is sufficient
    • If no RVR or EVR, extending duration to 72 weeks may be beneficial if HCV RNA undetectable at week 24 (if patient has advanced fibrosis and depending on tolerance of therapy)

Next: Genotype 2-3